|
Antitumor activity and safety of dostarlimab monotherapy in patients with mismatch repair deficient non-endometrial solid tumors: A post-hoc subgroup analysis of patients with colorectal cancer. |
|
|
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Pierre Fabre; Roche/Genentech; SERVIER; Ventana Medical Systems |
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Pierre Fabre; Seagen; SERVIER; Tesaro; Transgene |
Travel, Accommodations, Expenses - MSD Oncology |
|
|
Honoraria - BMS; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER |
Consulting or Advisory Role - Bristol-Myers Squibb; EMD SERONO; Incyte; Nerviano Medical Sciences; Novartis Italy; Roche; Sanofi; Teofarma |
Research Funding - Kymab (Inst); Loxo (Inst); Merck Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst) |
|
|
|
Travel, Accommodations, Expenses - Daiichi Sankyo |
|
|
No Relationships to Disclose |
|
|
Honoraria - Ellipses Pharma |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi-Sankyo; Foundation Medicine; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen |
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen |
Research Funding - Merck (Inst) |
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer |
Expert Testimony - Pfizer |
|
|
|
Consulting or Advisory Role - Amgen; Ipsen; Sanofi |
|
Travel, Accommodations, Expenses - Amgen; Lilly; Merck; Roche; Sanofi |
|
|
Stock and Other Ownership Interests - Abbvie; AstraZeneca (I); Bristol-Myers Squibb; GlaxoSmithKline (I); Pfizer |
Honoraria - AstraZeneca Canada; Bristol-Myers Squibb; Exact Sciences; Ipsen; Novartis Canada Pharmaceuticals Inc; Pfizer; Sandoz |
Research Funding - AstraZeneca Canada (Inst) |
|
|
Consulting or Advisory Role - AstraZeneca (Inst); GlaxoSmithKline; MSD Oncology (Inst) |
|
|
Honoraria - Bms spain; Roche |
Consulting or Advisory Role - BeiGene |
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bms Spain; MSD; Roche; Roche |
|
|
Consulting or Advisory Role - Merck; Pfizer; Taiho Pharmaceutical |
Speakers' Bureau - Amgen; Merck; Taiho Pharmaceutical |
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Merck (Inst) |
|
|
Employment - GlaxoSmithKline |
|
|
Employment - Abbott Laboratories (I); GlaxoSmithKline; Takeda (I) |
Stock and Other Ownership Interests - Abbvie (I) |
Honoraria - Michiana Hematology Oncology |
|
|
Employment - GlaxoSmithKline |
|
|
Honoraria - Amgen; GlaxoSmithKline; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER |
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer; SERVIER |
Research Funding - AstraZeneca (Inst); BMS (Inst); Pfizer/EMD Serono (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; BMS; Lilly; Merck; MSD Oncology; Roche |